Echo to Anesthesia Map 14

INTRODUCTION Morbid obesity is not merely an excess of body weight. It represents a chronic cardiometabolic disease state that exerts continuous stress on the cardiovascular system, leading to structural remodeling, functional impairment, and altered physiological reserve. For anesthesiologists, this distinction is critical: patients with extreme obesity and no “comorbidities” may already have advanced yet silent myocardial disease. Echocardiography has emerged as the most comprehensive perioperative cardiovascular assessment tool in bariatric anesthesia. It does not simply identify pathology; it quantifies functional reserve, reveals preload dependence, assesses pulmonary vascular physiology, and predicts vulnerability to anesthetic stress. Unlike electrocardiography or chest radiography, echocardiography delivers dynamic insight into ventricular compliance, atrial pressure burden, right heart mechanics, and volume responsiveness—variables that directly influence anesthetic management. This chapter applies echocardiographic interpretation to a typical bariatric surgery patient and translates imaging findings into practical anesthetic strategy. CASE SUMMARY A 50-year-old male with body mass index (BMI) of 50 kg/m² is scheduled for laparoscopic sleeve gastrectomy. He has no documented hypertension, diabetes, coronary disease, or heart failure. However, he reports poor exercise tolerance, loud snoring, and daytime somnolence suggesting undiagnosed obstructive sleep apnea. Given his extreme obesity and reduced functional capacity, preoperative transthoracic echocardiography was obtained in anticipation of cardiopulmonary stress from general anesthesia, pneumoperitoneum, and reverse Trendelenburg positioning. Despite the lack of overt cardiovascular disease, obesity itself imposes chronic hemodynamic stress leading to silent structural and functional cardiac remodeling. ECHOCARDIOGRAPHIC FINDINGS Structural and Functional Summary Two-dimensional measurements: Left ventricular end-diastolic diameter: 51 mm Left ventricular end-systolic diameter: 34 mm Interventricular septum thickness: 16 mm Posterior wall thickness: 16 mm Left atrial diameter: 49 mm Inferior vena cava diameter: 15 mm with respiratory collapse Functional data: Ejection fraction: 60% Fractional shortening: 32% Right ventricular size: normal Doppler parameters: Mitral E/A ratio ≈ 0.7 Reduced tissue Doppler e′ velocity Grade I diastolic dysfunction Valve assessment: Aortic sclerosis without stenosis Trivial mitral, tricuspid, and aortic regurgitation Integrated Impression Moderate concentric left ventricular hypertrophy, dilated left atrium, preserved systolic function, impaired relaxation, no pulmonary hypertension, and normal right ventricular size. WHY ECHOCARDIOGRAPHY MATTERS IN MORBID OBESITY Obesity imposes a sustained high-output circulatory state through increased metabolic demand and blood volume expansion. Over time, this results in: Increased left ventricular wall stress Elevated systemic vascular resistance Endothelial dysfunction Neurohormonal activation Pulmonary vascular remodeling At the cellular level, obesity leads to lipid infiltration of cardiomyocytes, interstitial fibrosis, impaired calcium cycling, and mitochondrial dysfunction. These mechanisms collectively reduce ventricular compliance and impair myocardial relaxation. This evolution produces an obesity cardiomyopathy phenotype characterized by concentric hypertrophy, left atrial enlargement, and diastolic dysfunction that often progresses to HFpEF. Echocardiography identifies these abnormalities long before clinical symptoms or ECG changes occur and remains the only noninvasive modality that integrates structure, function, and hemodynamics in a single study. INTERPRETATION FOR ANESTHESIA PRACTICE Concentric LV Hypertrophy A wall thickness of 16 mm represents pathological remodeling. This ventricle has a steep pressure–volume relationship with low compliance. It tolerates preload variation poorly and is prone to hypotension following anesthetic-induced vasodilation. Anesthetic relevance: Induction hypotension may be profound Rapid fluid boluses risk pulmonary edema Small decreases in preload cause major output reduction Left Atrial Dilation A left atrial diameter of 49 mm reflects chronically elevated filling pressures. The left atrium acts as a historical marker of diastolic burden and predicts perioperative heart failure and atrial arrhythmias. Clinical importance: Increased risk of atrial fibrillation Reduced pulmonary venous reserve Volume intolerance during anesthesia Diastolic Dysfunction Impaired relaxation limits ventricular filling, especially when heart rate increases. Diastolic dysfunction reduces the compensatory mechanisms that protect cardiac output during stress. Implications: Tachycardia causes rapid hemodynamic collapse Positive pressure ventilation worsens filling Pulmonary edema may develop with modest fluid loading Diastolic dysfunction is the dominant pathology in obese patients with preserved ejection fraction. Normal EF Does Not Mean Low Risk Preserved ejection fraction does not equate to preserved reserve. Patients with HFpEF can sustain normal systolic output only under stable physiological conditions. Anesthesia removes these stabilizing mechanisms, unmasking diastolic intolerance. ECHO-BASED ANESTHETIC PLANNING FRAMEWORK Pre-induction Phase Echocardiography identifies high-risk features: LV wall thickness >13 mm: hypotension risk LA dilation: fluid sensitivity Diastolic dysfunction: heart rate dependence Dilated IVC: limited reserve under positive pressure ventilation Key principles: Secure invasive monitoring early if indicated Avoid deep sedative premedication Maintain euvolemia and preload Have vasopressor infusion available before induction Induction Phase Induction should preserve sympathetic tone and avoid abrupt decreases in afterload. Recommended principles: Titrate induction agents Avoid propofol boluses Prefer balanced techniques (e.g., ketamine-based) Use norepinephrine early if hypotension develops Maintain sinus rhythm at all times Pneumoperitoneum and Positioning Physiologic changes during laparoscopy include: Reduced venous return Increased pulmonary vascular resistance Reduced stroke volume Increased right ventricular afterload Management strategy: Use the lowest effective insufflation pressure Minimize PEEP Limit abrupt recruitment maneuvers Monitor for RV dilation or septal shift with echocardiography when available Emergence Phase This is the most vulnerable period for pulmonary edema and arrhythmias. Dangers: Negative pressure pulmonary edema Hypertensive surges Flash pulmonary edema Atrial fibrillation Prevention: Gradual emergence Avoid excessive fluid before extubation Treat hypertension early Maintain positive airway pressure in high-risk patients ECHO IN CRISIS DIAGNOSIS QUANTITATIVE RISK THRESHOLDS LA ≥48 mm → high risk of pulmonary edema LV wall thickness ≥16 mm → anesthesia instability E/e′ >15 → elevated filling pressure RV dysfunction → poor tolerance of PPV WHEN TO POSTPONE SURGERY Surgery should be delayed for cardiac optimization if any of the following are present: Ejection fraction <35% Severe pulmonary hypertension Severe right ventricular dysfunction Restrictive filling pattern LV outflow tract obstruction Decompensated heart failure symptoms NORMAL VS OBESE HEART ADVANCED APPLICATIONS Use of TEE in Bariatric Anesthesia Indications: Unexplained hypotension Right ventricular dysfunction Pulmonary hypertension Difficult ventilation with instability Common Misinterpretations “Normal EF = normal heart” “Small LV means hypovolemia” “Large fluids fix hypotension” “LA size is not important” These assumptions lead directly to anesthetic harm. FINAL IMPRESSION This patient has obesity cardiomyopathy characterized by concentric hypertrophy, left atrial dilation, and diastolic dysfunction with preserved systolic function. The heart is stiff and preload-sensitive. Anesthetic stress threatens decompensation during induction, pneumoperitoneum, and emergence. CLINICAL BOTTOM LINE Echocardiography is not an investigation in morbid obesity — it is the foundation of anesthesia strategy. Ejection fraction reassures falsely. Diastology predicts truthfully. References Lang RM, Badano LP, Mor-Avi V, et al. Recommendations for cardiac chamber quantification by echocardiography in adults. Eur Heart J Cardiovasc Imaging. 2015;16(3):233–270. Nagueh SF, Smiseth OA, Appleton CP, et al. Recommendations for evaluation of left ventricular diastolic function. Eur J Echocardiogr. 2016;17(12):1321–1360. Poirier P, Giles TD, Bray GA, et al. Obesity and cardiovascular disease. Circulation. 2006;113(6):898–918. Alpert MA, Karthikeyan K, Abdullah O, Ghadban R. Obesity and cardiac structure and function. J Am Coll Cardiol. 2014;63(12):1179–1186. Peterson LR, Waggoner AD, Schechtman KB, et al. Alterations in LV structure and function in obesity. Circulation. 2004;109(18):2191–2196. Wong CY, O’Moore-Sullivan T, Leano R, et al. Alterations of LV myocardial function in obesity. J Am Coll Cardiol. 2004;43(8):139–144. Ganau A, Devereux RB, Roman MJ, et al. Patterns of LV hypertrophy and cardiovascular risk. J Am Coll Cardiol. 1992;19(7):1550–1558. Schwartzenberg S, Redfield MM, From AM, et al. Diastolic dysfunction in obese patients. Am J Cardiol. 2012;110(11):1655–1660. Tsang TS, Barnes ME, Gersh BJ, et al. Left atrial volume and cardiovascular outcomes. J Am Coll Cardiol. 2002;40(6):1018–1025. Møller JE, Hillis GS, Oh JK, et al. LA size and mortality. Heart. 2003;89(1):72–77. Redfield MM, Jacobsen SJ, Burnett JC, et al. Burden of diastolic dysfunction. JAMA. 2003;289(2):194–202. Paulus WJ, Tschöpe C. Pathophysiology of HFpEF. J Am Coll Cardiol. 2013;62(4):263–271. Shah SJ. Classification of HFpEF. J Am Coll Cardiol. 2017;70(13):1684–1699. Borlaug BA. Obesity, HFpEF, and diastolic dysfunction. Circ Heart Fail. 2014;7(2):219–227. Pinsky MR. Cardiopulmonary interactions in anesthesia and ICU. Chest. 2018;154(6):1308–1321. Shibata S, Miura S, Zhang R, et al. Obesity and preload dependence. Circulation. 2011;124(4):438–447. Magder S. Volume status and venous return. Crit Care. 2016;20(1):271. Michard F, Teboul JL. Predicting fluid responsiveness. Intensive Care Med. 2002;28(1):6–13. Hirvonen EA, Nuutinen LS, Kauko M. Hemodynamics during laparoscopy. Br J Anaesth. 1995;75(5):570–575. Nguyen NT, Wolfe BM. The physiology of pneumoperitoneum. Surg Endosc. 2001;15(8):875–880. Lemyze M, Mallat J. Negative pressure pulmonary edema. Intensive Care Med. 2014;40(8):1140–1147. Vieillard-Baron A, Millington SJ, Sanfilippo F, et al. Echo in shock management. Intensive Care Med. 2016;42(9):1408–1420. Abhayaratna WP, Seward JB, Appleton CP, et al. Left atrial size and prognosis. J Am Coll Cardiol. 2006;47(5):1018–1023. Fleisher LA, Fleischmann KE, Auerbach AD, et al. 2014 ACC/AHA guideline on perioperative cardiovascular evaluation. Circulation. 2014;130(24):2215–2245. Lavie CJ, Alpert MA, Arena R, et al. Obesity cardiomyopathy. Prog Cardiovasc Dis. 2014;56(4):423–434. Shillcutt SK, Markin NW, Montzingo CR, et al. Perioperative TEE guidelines. Anesth Analg. 2018;126(4):1125–1140. Oh JK, Park SJ, Nagueh SF. Pitfalls in diastolic assessment. J Am Soc Echocardiogr. 2011;24(3):277–282.